Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrike Friebe-Hoffmann

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
International Journal of Cancer|February 12, 2009
A novel mechanism for anti-EGFR antibody action involves chemokine-mediated leukocyte infiltrationThomas K Hoffmann, Kerstin Schirlau, Enikö Sonkoly, et al.
American Journal of Obstetrics & Gynecology MFM|March 9, 2024
Pentaerythrityl tetranitrate improves the outcome of children born to mothers with compromised uterine perfusion-12-months follow-up and safety data of the double-blind randomized PETN trialTanja Groten, Thomas Lehmann, Mariann Städtler, et al.
American Journal of Obstetrics and Gynecology|August 5, 2022
Effect of pentaerythritol tetranitrate (PETN) on the development of fetal growth restriction in pregnancies with impaired uteroplacental perfusion at midgestation-a randomized trialTanja Groten, Thomas Lehmann, Mariann Städtler, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
International Journal of Cancer|February 12, 2009
A novel mechanism for anti-EGFR antibody action involves chemokine-mediated leukocyte infiltrationThomas K Hoffmann, Kerstin Schirlau, Enikö Sonkoly, et al.
American Journal of Obstetrics & Gynecology MFM|March 9, 2024
Pentaerythrityl tetranitrate improves the outcome of children born to mothers with compromised uterine perfusion-12-months follow-up and safety data of the double-blind randomized PETN trialTanja Groten, Thomas Lehmann, Mariann Städtler, et al.
American Journal of Obstetrics and Gynecology|August 5, 2022
Effect of pentaerythritol tetranitrate (PETN) on the development of fetal growth restriction in pregnancies with impaired uteroplacental perfusion at midgestation-a randomized trialTanja Groten, Thomas Lehmann, Mariann Städtler, et al.
Pageof 3